Filtyp
In this chapter we explore the temporal dynamics of using forest bioenergy to mitigate climate change. We consider such issues as: growth dynamics of forests under different management regimes; the substitution effects of different bioenergy and biomaterial uses; temporary carbon storage in harvested biomass; the availability of different biomass fractions at different points of a wood product lif
We estimate the climate effects of directing forest management in Sweden towards increased carbon storage in forests with more land set-aside for protection, or towards increased forest production for the substitution of carbon-intensive materials and fossil fuels, relative to a reference case of current forest management. We develop various scenarios of forest management and biomass use to estima
The Art of Fusion
Processing of complex cell preparations such as blood and peripheral blood progenitor cell (PBPC) transplants using label-free technologies is challenging. Transplant-contaminating neuroblastoma cells (NBCs) can contribute to relapse, and we therefore aimed to provide proof-of-principle evidence that label-free acoustophoretic separation can be applied for diagnostic NBC enrichment and removal ("p
Numerical analysis have been performed on tensile test experiment data to evaluated the performances of a 9 microns thick aluminium foil. The identification of the anisotropic material properties is based on tensile tests performed in 11 di↵erent angles from 0 to 90 from the rolling direction. By least square fitting and extrapolation to zero load the elastic modulus is, as opposed to the general Numerical analysis have been performed on tensile test experiment data toevaluated the performances of a 9 microns thick aluminium foil. The identification of theanisotropic material properties is based on tensile tests performed in 11 different anglesfrom 0◦to 90◦from the rolling direction. By least square fitting and extrapolation tozero load the elastic modulus is, as opposed to the general bel
Primary prevention of type 1 diabetes (T1D) requires intervention in genetically at-risk infants. The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) has established a screening program, GPPAD-02, that identifies infants with a genetic high risk of T1D, enrolls these into primary prevention trials, and follows the children for beta-cell autoantibodies and diabetes. Genetic testin
